Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate a safe and useful medication for outpatient detoxification that is
as effective as benzodiazepines in the short-term, and more effective in the protracted
withdrawal period. Gabapentin (Neurontin) will be compared to a standard benzodiazepine,
lorazepam (Ativan), for its effectiveness in treating alcohol withdrawal.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)